litlas
ログインアカウント作成

Teru Hideshima

1989–2024 年に発表

206
論文数
47,604
被引用数
122
h 指数
206
i10 指数

被引用数

Teru Hideshima の年別被引用数1976 年: 被引用 1 件1986 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 3 件1991 年: 被引用 6 件1992 年: 被引用 19 件1993 年: 被引用 11 件1994 年: 被引用 11 件1995 年: 被引用 10 件1996 年: 被引用 2 件1997 年: 被引用 8 件1998 年: 被引用 5 件1999 年: 被引用 5 件2000 年: 被引用 11 件2001 年: 被引用 52 件2002 年: 被引用 225 件2003 年: 被引用 513 件2004 年: 被引用 575 件2005 年: 被引用 698 件2006 年: 被引用 764 件2007 年: 被引用 926 件2008 年: 被引用 731 件2009 年: 被引用 703 件2010 年: 被引用 646 件2011 年: 被引用 698 件2012 年: 被引用 609 件2013 年: 被引用 510 件2014 年: 被引用 516 件2015 年: 被引用 463 件2016 年: 被引用 391 件2017 年: 被引用 381 件2018 年: 被引用 318 件2019 年: 被引用 1,044 件2020 年: 被引用 1,140 件2021 年: 被引用 1,066 件2022 年: 被引用 741 件2023 年: 被引用 476 件2024 年: 被引用 684 件2025 年: 被引用 281 件2026 年: 被引用 6 件1977〜1985 年は被引用が無いため表示していません1987〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,221 件、この内訳の 31.9%中国: 引用元論文 1,524 件、この内訳の 11.5%イタリア: 引用元論文 766 件、この内訳の 5.8%ドイツ: 引用元論文 703 件、この内訳の 5.3%イギリス: 引用元論文 661 件、この内訳の 5%フランス: 引用元論文 452 件、この内訳の 3.4%日本: 引用元論文 380 件、この内訳の 2.9%スペイン: 引用元論文 341 件、この内訳の 2.6%カナダ: 引用元論文 313 件、この内訳の 2.4%オーストラリア: 引用元論文 302 件、この内訳の 2.3%オランダ: 引用元論文 284 件、この内訳の 2.2%インド: 引用元論文 269 件、この内訳の 2%
0%31.9%その他 22.7%

機関

分野

  • Medicine45.9%
  • Biochemistry, Genetics and Molecular Biology42.8%
  • Immunology and Microbiology7.2%
  • Chemistry0.8%
  • Computer Science0.6%
  • Neuroscience0.5%
  • その他2.2%

トピック

  • Multiple Myeloma Research and Treatments9.1%
  • Ubiquitin and proteasome pathways5.4%
  • Protein Degradation and Inhibitors5.3%
  • Histone Deacetylase Inhibitors Research3.7%
  • Peptidase Inhibition and Analysis3.3%
  • Cell death mechanisms and regulation2%
  • その他71.2%

共著者

全論文

検索で開く
  1. A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance

    著者: Dharminder Chauhan, Ze Tian, Benjamin Nicholson, Suresh Kumar, Bin Zhou, Ruben D. Carrasco, Jeffrey L. McDermott, Craig A. Leach, Mariaterresa Fulcinniti, Matthew P. Kodrasov, Joseph Weinstock, William D. Kingsbury, Teru Hideshima, Parantu K. Shah, Stéphane Minvielle, Mikael Altun, Benedikt M. Kessler, Robert Z. Orlowski, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Cancer Cell 2012 被引用: 581

  2. Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

    著者: Annamaria Gullà, Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, Stefano Malvestiti, Rao Prabhala, Srikanth Talluri, Kenneth Wen, Yu‐Tzu Tai, Paul G. Richardson, Dharminder Chauhan, Tomasz Sewastianik, Ruben D. Carrasco, Nikhil C. Munshi, Kenneth C. Anderson - Blood Cancer Discovery 2021 被引用: 137

  3. The proteasome and proteasome inhibitors in multiple myeloma

    著者: Sara Gandolfi, Jacob P. Laubach, Teru Hideshima, Dharminder Chauhan, Kenneth C. Anderson, Paul G. Richardson - Cancer and Metastasis Reviews 2017 被引用: 349

  4. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans

    著者: Güllü Görgün, Gregory Whitehill, Jennifer L. Anderson, Teru Hideshima, Craig Maguire, Jacob P. Laubach, Noopur Raje, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson - Blood 2013 被引用: 387

  5. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

    著者: Paul G. Richardson, Bart Barlogie, James R. Berenson, Seema Singhal, Sundar Jagannath, David Irwin, S. Vincent Rajkumar, Gordan Srkalović, Melissa Alsina, Raymond Alexanian, David S. Siegel, Robert Z. Orlowski, David J. Kuter, Steven Limentani, Stephanie J. Lee, Teru Hideshima, Dixie‐Lee Esseltine, Michael Kauffman, Julian Adams, David P. Schenkein, Kenneth C. Anderson - New England Journal of Medicine 2003 被引用: 2,641

  6. Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma

    著者: Jooeun Bae, Fabrizio Accardi, Teru Hideshima, Yu‐Tzu Tai, Rao Prabhala, Aaron Shambley, Kenneth Wen, Sean Rowell, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Leukemia 2021 被引用: 75

  7. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

    著者: Loredana Santo, Teru Hideshima, Andrew L. Kung, Jen‐Chieh Tseng, David Tamang, Min Yang, Matthew Jarpe, John H. van Duzer, Ralph Mazitschek, Walter C. Ogier, Diana Cirstea, Scott J. Rodig, Homare Eda, Tyler Scullen, Miriam Canavese, James E. Bradner, Kenneth C. Anderson, Simon S. Jones, Noopur Raje - Blood 2012 被引用: 601

  8. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets

    著者: Teru Hideshima, Constantine S. Mitsiades, Giovanni Tonon, Paul G. Richardson, Kenneth C. Anderson - Nature reviews. Cancer 2007 被引用: 935

  9. Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

    著者: Yu‐Tzu Tai, Myles Dillon, Weihua Song, Merav Leiba, Xian-Feng Li, Peter Burger, Alfred Ian Lee, Klaus Podar, Teru Hideshima, Audie Rice, Anne van Abbema, Lynne Jesaitis, Ingrid W. Caras, Debbie A. Law, Edie Weller, Wanling Xie, Paul G. Richardson, Nikhil C. Munshi, Claire Mathiot, Hervé Avet‐Loiseau, Daniel Afar, Kenneth C. Anderson - Blood 2007 被引用: 473

  10. Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers

    著者: Francesca Cottini, Teru Hideshima, Chunxiao Xu, Martin Sattler, Martina Dori, Luca Agnelli, Elisa ten Hacken, Maria Teresa Sabrina Bertilaccio, Elena Antonini, Antonino Neri, Maurilio Ponzoni, Magda Marcatti, Paul G. Richardson, Ruben D. Carrasco, Alec C. Kimmelman, Kwok‐Kin Wong, Federico Caligaris‐Cappio, Giovanni Blandino, W. Michael Kuehl, Kenneth C. Anderson, Giovanni Tonon - Nature Medicine 2014 被引用: 310

  11. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma

    著者: Güllü Görgün, Mehmet Samur, Kristen Cowens, Steven Paula, Giada Bianchi, J Anderson, Randie E. White, Ahaana Singh, Hiroto Ohguchi, Rikio Suzuki, Shohei Kikuchi, Takeshi Harada, Teru Hideshima, Yu‐Tzu Tai, Jacob P. Laubach, Noopur Raje, Florence Magrangeas, Stéphane Minvielle, Hervé Avet‐Loiseau, Nikhil C. Munshi, David M. Dorfman, Paul G. Richardson, Kenneth C. Anderson - Clinical Cancer Research 2015 被引用: 305

  12. Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

    著者: Dharminder Chauhan, Ajita Singh, Mohan Brahmandam, Ruben D. Carrasco, Madhavi Bandi, Teru Hideshima, Giada Bianchi, Klaus Podar, Yu-Tzu Tai, Constantine S. Mitsiades, Noopur Raje, David L. Jaye, Shaji Kumar, Paul G. Richardson, Nikhil C. Munshi, Kenneth C. Anderson - Cancer Cell 2009 被引用: 297

  13. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors

    著者: Jooeun Bae, Teru Hideshima, Yu‐Tzu Tai, Yan Song, Paul G. Richardson, Noopur Raje, Nikhil C. Munshi, Kenneth C. Anderson - Leukemia 2018 被引用: 118

  14. Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

    著者: Faith E. Davies, Noopur Raje, Teru Hideshima, Suzanne Lentzsch, Gloria Young, Yu‐Tzu Tai, Boris K. Lin, Klaus Podar, Deepak Gupta, Dharminder Chauhan, Steven P. Treon, Paul G. Richardson, Robert Schlossman, Gareth J. Morgan, George W. Muller, David Stirling, Kenneth C. Anderson - Blood 2001 被引用: 905

  15. BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma

    著者: Keiji Kurata, Mehmet Samur, Priscilla Liow, Kenneth Wen, Leona Yamamoto, Jiye Liu, Eugenio Morelli, Annamaria Gullà, Yu‐Tzu Tai, Jun Qi, Teru Hideshima, Kenneth C. Anderson - Clinical Cancer Research 2023 被引用: 33

  16. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

    著者: Teru Hideshima, Paul G. Richardson, D Chauhan, Vito J. Palombella, Peter J. Elliott, Julian Adams, K C Anderson - 2001 被引用: 1,530

  17. Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells

    著者: Teru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, Yutaka Okawa, Noopur Raje, Klaus Podar, Constantine S. Mitsiades, Nikhil C. Munshi, Paul G. Richardson, Ruben D. Carrasco, Kenneth C. Anderson - Blood 2009 被引用: 371

  18. The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications

    著者: Daisuke Ogiya, Jiye Liu, Hiroto Ohguchi, Keiji Kurata, Mehmet Samur, Yu‐Tzu Tai, Sophia Adamia, Kiyoshi Ando, Teru Hideshima, Kenneth C. Anderson - Blood 2020 被引用: 87

  19. Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

    著者: Richard LeBlanc, Teru Hideshima, Laurence Catley, Reshma Shringarpure, Renate Burger, Nicholas Mitsiades, Constantine S. Mitsiades, P. Cheema, Dharminder Chauhan, Paul G. Richardson, Kenneth C. Anderson, Nikhil C. Munshi - Blood 2003 被引用: 286

  20. Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

    著者: Annamaria Gullà, Teru Hideshima, Giada Bianchi, Mariateresa Fulciniti, Mehmet Samur, Jun Qi, Y-T Tai, Takeshi Harada, Eugenio Morelli, Nicola Amodio, Ruben D. Carrasco, Pierosandro Tagliaferri, Nikhil C. Munshi, Pierfrancesco Tassone, Kenneth C. Anderson - Leukemia 2017 被引用: 98

  21. A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growth

    著者: Eugenio Morelli, Mariateresa Fulciniti, Mehmet Samur, Caroline F. Ribeiro, León Wert-Lamas, Jonathan E. Henninger, Annamaria Gullà, Anıl Aktaş Samur, Katia Todoerti, Srikanth Talluri, Woojun D. Park, Cinzia Federico, Francesca Scionti, Nicola Amodio, Giada Bianchi, Megan Johnstone, Na Liu, Doriana Gramegna, Domenico Maisano, Nicola Antonino Russo, Charles Y. Lin, Yu‐Tzu Tai, Antonino Neri, Dharminder Chauhan, Teru Hideshima, Masood A. Shammas, Pierfrancesco Tassone, Sergei Gryaznov, Richard A. Young, Kenneth C. Anderson, Carl D. Novina, Massimo Loda, Nikhil C. Munshi - Blood 2022 被引用: 35

  22. Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma

    著者: Teru Hideshima, Jun Qi, Ronald M. Paranal, Weiping Tang, Edward F. Greenberg, Nathan West, Meaghan Colling, Guillermina Estiú, Ralph Mazitschek, Jennifer A. Perry, Hiroto Ohguchi, Francesca Cottini, Naoya Mimura, Güllü Görgün, Yu‐Tzu Tai, Paul G. Richardson, Ruben D. Carrasco, Olaf Wiest, Stuart L. Schreiber, Kenneth C. Anderson, James E. Bradner - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 被引用: 139

  23. Signaling Pathway Mediating Myeloma Cell Growth and Survival

    著者: Teru Hideshima, Kenneth C. Anderson - Cancers 2021 被引用: 68

  24. Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

    著者: Jiye Liu, Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu, Gongwei Wu, Su Wang, Daisuke Ogiya, Tianyu Song, Keiji Kurata, Johany Peñailillo, Eugenio Morelli, Tingjian Wang, Xiaoning Hong, Annamaria Gullà, Yu‐Tzu Tai, Nikhil C. Munshi, Paul G. Richardson, Ruben D. Carrasco, Teru Hideshima, Kenneth C. Anderson - Nature Communications 2024 被引用: 34